Status:
TERMINATED
Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma
Lead Sponsor:
University of Minnesota
Conditions:
Cutaneous T-Cell Lymphoma
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to define the mechanisms that underlie the refractory pruritus (itch) in Cutaneous T-Cell Lymphoma (CTCL).
Detailed Description
Little is known about the fundamental cause of pruritus in CTCL, however we do know the malignant CD4+ T-cells of CTCL accumulate in the epidermis and are in close proximity to the neural, immune and ...
Eligibility Criteria
Inclusion
- Patients with CTCL
Exclusion
- None
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00863395
Start Date
December 1 2008
End Date
December 1 2012
Last Update
March 31 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455